Theme 2 - the role of antibodies in Covid infection

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-516

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Emma Wall
  • Research Location

    United Kingdom
  • Lead Research Institution

    Francis Crick Institute
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The Legacy Study will utilise a unique bank of over 400,000 coronavirus samples at the Crick, gathered as part of the institute's testing partnership with many north London healthcare facilities, including UCLH. Scientists and clinicians will aim to understand the coronavirus and how it behaves in individuals - how the virus is transmitted between people, how later stages of the disease develop and how the body's immune system attempts to control the virus. ... "With informed consent, samples will be matched with individuals to establish how factors like age, sex, ethnicity, and past and current medical histories, impact the risk of infection. Participants will also be invited to give regular swab and blood samples over two years, to better understand how emerging variants and vaccination affect risk of infection and how the body responds." - from Crick news article August 2021.